In an orthotopic bladder cancer model [106], an R11 peptide-modified nanoparticle was developed: the R11 peptide forms hydrogen bonds with integrin β1, enhancing nanoparticle binding to tumour cells via the Piezo1/integrin β1 signalling axis. The gene discussed is PIEZO1; the disease is neoplasm.